Article Text

Download PDFPDF

British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin
  1. Marie-Helene Marion1,2,
  2. Miles Humberstone3,4,
  3. Richard Grunewald5,
  4. Sunil Wimalaratna6
  1. 1London BTX Centre, London, UK
  2. 2British Neurotoxin Network, Guildford, UK
  3. 3Department of Neurology, Nottingham University Hospitals, Nottingham, UK
  4. 4Department of Neurology, United Lincolnshire Hospitals, Lincoln, UK
  5. 5Department of Neurology, Sheffield Teaching Hospitals NHS FT, Sheffield, UK
  6. 6Department of Neurology, Kettering General Hospital NHS Foundation Trust, Kettering, UK
  1. Correspondence to Dr Marie-Helene Marion, London BTX Centre, 9a Wilbraham Place Practice, London SW1X 9AE, UK; mariehelenemarion{at}gmail.com

Abstract

Botulinum toxin (BoNT) injections are an effective treatment for cervical dystonia. Approximately 20% of patients eventually stop BoNT treatment, mostly because of treatment failure. These recommendations review the different therapeutic interventions for optimising the treatment in secondary poor responder patients. Immunoresistance has become less common over the years, but the diagnosis has to be addressed with a frontalis test or an Extensor Digitorum Brevis test. In case of immunoresistance to BoNT-A, we discuss the place the different therapeutic options (BoNT-A holidays, BoNT-B injections, alternative BoNT-A injections, deep brain stimulation). When poor responders are not immunoresistant, they benefit from reviewing (1) injections technique with electromyography or ultrasound guidance, (2) muscles selection and (3) dose of BoNT. In addition, in both scenarios, a holistic approach including drug treatment, retraining and psychological support is valuable in the management of these complex and severe cervical dystonia.

  • BOTULINUM TOXIN
  • cervical dystonia
  • poor responders to treatment
  • British Neurotoxin Network
  • BNN guidelines

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Editors' commentary
    Phil E M Smith Geraint N Fuller

Other content recommended for you